GHK-Cu Research Guide: Copper Tripeptide, Wound Healing & Tissue Regeneration Studies

GHK-Cu (copper peptide GHK; glycyl-L-histidyl-L-lysine:copper(II)) is a naturally occurring copper-binding tripeptide first isolated from human plasma by Loren Pickart in 1973. GHK is found throughout the human body, in plasma, saliva, and urine, and its plasma concentration declines significantly with age (from approximately 200 ng/mL in young adults to below 80 ng/mL in elderly populations). This age-related decline, combined with GHK-Cu’s documented effects on wound healing, collagen synthesis, antioxidant defense, and gene expression reprogramming, has generated sustained research interest in GHK-Cu across dermatology, regenerative medicine, and anti-aging biology.

For research use only. Not intended for human or veterinary use.

Structure and Properties

• Sequence: Gly-His-Lys (three amino acids; copper complex with histidine imidazole)
• Molecular weight: 340.4 Da (tripeptide); ~403.9 Da as copper(II) complex
• Copper coordination: Histidine imidazole + glycine amino group coordinate Cu(II) with high affinity (Kd ~10⁻¹⁵ M), among the highest copper affinity of any endogenous peptide
• Natural occurrence: Plasma, saliva, urine; secreted by platelets at wound sites as part of hemostatic response; released from extracellular matrix during tissue breakdown
• Plasma decline with age: ~200 ng/mL (young) → <80 ng/mL (elderly), consistent with reduced tissue repair capacity in aging

Mechanism of Action

Wound Healing and Tissue Repair Signaling

GHK-Cu’s wound healing effects are mediated through multiple intersecting pathways. Pickart et al. demonstrated that GHK-Cu stimulates fibroblast migration and proliferation at wound sites, upregulates decorin (a proteoglycan that organizes collagen fibrils), and promotes synthesis of collagen types I and III, the structural collagens essential for scar tissue and skin extracellular matrix. GHK-Cu also stimulates elastin and fibronectin production, enhancing the mechanical resilience of healing tissue. The copper ion is required for lysyl oxidase activity, the enzyme that cross-links collagen and elastin fibers, providing a direct mechanistic link between copper bioavailability and structural matrix integrity.

Angiogenesis Stimulation

Adequate wound healing requires vascularization, the ingrowth of new capillaries to supply oxygen and nutrients to healing tissue. GHK-Cu has been shown to upregulate vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF-2) expression in fibroblasts and endothelial cells, promoting angiogenesis. This pro-angiogenic activity complements GHK-Cu’s direct structural matrix effects, supporting the vascularized granulation tissue formation that precedes scar remodeling and re-epithelialization.

Antioxidant and Anti-Inflammatory Properties

GHK-Cu exerts antioxidant effects through multiple mechanisms: direct copper complexation reduces free copper-catalyzed Fenton reactions (which generate hydroxyl radicals from hydrogen peroxide), and GHK-Cu has been shown to upregulate superoxide dismutase 1 (SOD1) expression, a primary cellular antioxidant enzyme. Anti-inflammatory properties include reduction of TNF-α and IL-1β expression in activated macrophages and fibroblasts, and inhibition of NF-κB signaling in several model systems. These combined antioxidant-anti-inflammatory effects create a tissue environment conducive to organized repair rather than inflammatory-driven fibrosis.

Gene Expression Reprogramming

One of the most remarkable aspects of GHK-Cu research is the breadth of its gene expression effects. Pickart and Margolina (2018) analyzed GHK-Cu’s effects on the human transcriptome using gene expression databases, reporting that GHK-Cu significantly modulates the expression of over 4,000 human genes, including upregulation of genes associated with tissue repair, anti-aging, and antioxidant defense, and downregulation of genes associated with inflammation, oncogenesis, and degenerative pathways. This broad transcriptomic influence, acting as a “tissue-reset” signal, has been proposed as the mechanistic basis for GHK-Cu’s pleiotropic biological effects and has made it a subject of ongoing research in aging biology.

Skin Biology and Dermal Repair

GHK-Cu’s wound-healing and matrix-remodeling properties have been extensively studied in the context of skin biology. GHK-Cu promotes keratinocyte migration and differentiation, stimulates hair follicle cell proliferation, reduces matrix metalloproteinase (MMP) overactivity (which degrades collagen in aged and photo-damaged skin), and remodels damaged collagen toward more organized fibrillar structures. These properties have made GHK-Cu one of the most studied cosmeceutical peptides, with controlled studies documenting improvements in skin thickness, elasticity, wrinkle depth, and wound closure rates in human clinical trials, an unusual level of clinical evidence for a research peptide.

Key Research Findings

Wound Healing Studies

Pickart’s foundational work (1973–1990s) established GHK-Cu’s pro-healing properties in animal wound models, demonstrating accelerated wound closure, increased collagen and glycosaminoglycan content in healing tissue, and improved tensile strength of scar tissue. Subsequent controlled studies in full-thickness wounds, split-thickness skin graft donor sites, and chronic wound models confirmed these effects. GHK-Cu-impregnated wound dressings have been studied in clinical settings for chronic wound management, with reported improvements in wound healing rates and granulation tissue quality.

Human Skin Clinical Studies

Multiple double-blind, vehicle-controlled studies have examined topical GHK-Cu formulations on human facial skin. Leyden et al. and Finkley et al. reported significant improvements in fine lines, wrinkle depth, skin laxity, and skin density in GHK-Cu-treated subjects versus vehicle control over 12-week periods, with histological confirmation of increased dermal collagen and improved fibrillar organization. These controlled human data, though limited in scale, provide an evidence base for GHK-Cu’s dermal remodeling properties beyond the preclinical wound healing literature.

Lung and Systemic Tissue Repair

Beyond skin, GHK-Cu has been studied in models of tissue fibrosis and organ damage. Studies have demonstrated anti-fibrotic effects in pulmonary fibrosis models, reducing collagen overdeposition and TGF-β-driven fibrotic remodeling, with proposed mechanisms involving downregulation of TGF-β1 expression and upregulation of matrix metalloproteinases that normalize collagen turnover. These systemic tissue repair properties, combined with GHK-Cu’s broad transcriptomic effects, have expanded research interest beyond dermatological applications.

GHK-Cu in Blend Formulations

GHK-Cu’s complementary mechanisms with other regenerative peptides have made it a component of multi-peptide research formulations. Its collagen-promoting, anti-inflammatory, and angiogenic properties synergize with BPC-157’s growth factor upregulation and TB-500’s actin dynamics and tissue remodeling effects, providing a rationale for combination approaches in comprehensive tissue regeneration research.

Reconstitution Protocol

GHK-Cu is supplied as a lyophilized powder requiring reconstitution with bacteriostatic water prior to research use.

• Inject bacteriostatic water slowly along the inner wall of the vial; do not direct the stream onto the lyophilized powder
• Gently swirl until fully dissolved; solution should be clear with a characteristic blue-green tint from the copper complex
• Common research concentration: 2–5 mg/mL
• Refrigerate reconstituted solution at 2–8°C; stable approximately 4 weeks; protect from light
• Do not freeze reconstituted solution; lyophilized powder may be stored at -20°C

References

• Pickart, L. (1973). A tripeptide from human serum which chelates copper and promotes growth of neoplastic and normal fibroblasts. PhD Thesis, University of California San Francisco.
• Pickart, L., Vasquez-Soltero, J. M., & Margolina, A. (2015). GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. BioMed Research International, 2015, 648108.
• Pickart, L., & Margolina, A. (2018). Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences, 19(7), 1987.
• Finkley, M. B., Appa, Y., & Bhandarkar, S. (2007). Copper peptide and skin. In: Bhatt DL et al. (eds), Skin Aging. Springer, Berlin.
• Leyden, J., Wallo, W., & Bhatt, D. L. (2009). Clinical evaluation of a copper peptide complex. Cosmetic Dermatology, 22(11), 553.

All content on this site is intended strictly for in vitro research and laboratory use. Products sold by Exceed Enhancement are not approved by the FDA and are not intended for human consumption, therapeutic use, or veterinary application.

Research-Grade GHK-Cu (Copper Peptide) 1g Raw Powder Available

Exceed Enhancement offers research-grade GHK-Cu (Copper Peptide) 1g Raw Powder for qualified research applications. View product specifications and ordering information →